AMLN
NEW YORK, Aug 22 (Reuters) - The shares of Amylin Pharmaceuticals Inc. (AMLN.O: Quote, Profile, Research) and Alkermes Inc. (ALKS.O: Quote, Profile, Research) surged on Monday in after-hours trading after the drug makers announced positive results in a study of one of their joint diabetes treatments.
Budd Foxx
Budd Foxx
posted by Gordengekko at 5:35 PM
1 Comments:
Looks like the shorts are going to get worked this week.
Gekko
Post a Comment
<< Home